{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:54:31Z","timestamp":1793843671515,"version":"4.6.1"},"reference-count":65,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI152084"],"award-info":[{"award-number":["U01AI152084"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017037","name":"Cepheid","doi-asserted-by":"publisher","award":["Research grant"],"award-info":[{"award-number":["Research grant"]}],"id":[{"id":"10.13039\/100017037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2026,5,13]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Tuberculosis (TB) is a global health threat complicated by increasing INH resistance (INH-R) and rifampicin resistance (RIF-R), including RIF-R due to\n                      <jats:italic toggle=\"yes\">rpoB<\/jats:italic>\n                      Ile491Phe (I491F) mutations, which are not detected by current molecular resistance tests. We developed a low\u2010complexity automated nucleic acid amplification test MDRmDx, designed to operate on the 10-color GeneXpert instrument, which detects\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      (MTB), and RIF-R in both the rifampicin resistance determining region (RRDR) and the I491F allele, and INH-R due to mutations in\n                      <jats:italic toggle=\"yes\">katG<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">fabG1<\/jats:italic>\n                      , and the\n                      <jats:italic toggle=\"yes\">inhA<\/jats:italic>\n                      promoter directly from sputum. In an analytic study, the limit of detection (LoD) for detecting MTB in sputum was 21.6 CFU\/mL (95% confidence interval [CI]: 14.9\u201328.3) for the MDRmDx assay, versus 19.1 CFU\/mL (95% CI: 14.0\u201324.1) for the Xpert MTB\/RIF Ultra assay (Ultra). The LoD for rifampicin susceptibility (RIF-S) detection was 108.8 CFU\/mL (95% CI: 77.4\u2013140.2) versus 100.9 CFU\/mL (95% CI: 67.3\u2013134.5) for MDRmDx versus Ultra. The LoD for INH susceptibility detection was 92.2 CFU\/mL (95% CI: 65.3\u2013119.1). MDRmDx identified all\n                      <jats:italic toggle=\"yes\">rpoB<\/jats:italic>\n                      mutations with a \u22650.5% global prevalence, including several not detected by Ultra. MDRmDx was 100% specific. Testing frozen sputum enriched for smear-negative, RIF-R, and INH-R samples, MDRmDx sensitivity was 91.3% (95% CI: 85.6\u201394.8) for MTB detection, 100% (95% CI: 95.1\u2013100) for RIF resistance, and 98.7% (95% CI: 93.0\u201399.8) for INH resistance, with a specificity of 98.0% (95% CI: 89.3\u201399.6) for MTB detection, 93.8% (95% CI: 83.2\u201397.9) for RIF resistance, performance comparable to Ultra. MDRmDx specificity for INH-R was 100% (95% CI: 90.8\u2013100).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      The Xpert MTB\/RIF Ultra assay (Ultra) is a gold standard test for rapidly diagnosing tuberculosis (TB) as well as resistance to rifampicin directly from sputum samples. However, the Ultra assay does not detect certain rifampicin resistance mutations, which are observed clinically and cannot detect resistance to isoniazid, another key drug against TB. We modified the Ultra assay, creating a prototype MDRmDx assay designed for 10-color instruments that detects isoniazid resistance, which can be a precursor of potential rifampicin resistance and has improved ability to detect rifampicin resistance. In both analytic and retrospectively collected clinical sputum samples, we found that the MDRmDx assay performed at least as well as the Ultra assay with the additional advantage of detecting isoniazid resistance and\n                      <jats:italic toggle=\"yes\">rpoB<\/jats:italic>\n                      I491F mutations with high sensitivity and specificity. The MDRmDx assay's improved performance should improve detection of drug-resistant TB and facilitate the selection of effective treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jcm.01100-25","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:00:36Z","timestamp":1774875636000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["A cartridge-based assay for improved detection of multidrug-resistant\n                    <i>Mycobacterium tuberculosis<\/i>\n                    directly from sputum"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8980-2078","authenticated-orcid":false,"given":"Paulami","family":"Rudra","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heta","family":"Parmar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naranjargal","family":"Daivaa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Tran","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshika","family":"Narang","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranjit","family":"Singh","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhara","family":"Somaiya","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samarpita","family":"Roybardhan","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Anwesa","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Reiss","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Ward","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01e92na05","id-type":"ROR","asserted-by":"publisher"}],"name":"Frontier Science Foundation","place":["Brookline, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-0059","authenticated-orcid":true,"given":"Adam","family":"Penn-Nicholson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tcsqz68","id-type":"ROR","asserted-by":"publisher"}],"name":"Foundation for Innovative New Diagnostics","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3059-2986","authenticated-orcid":true,"given":"Margaretha","family":"De Vos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tcsqz68","id-type":"ROR","asserted-by":"publisher"}],"name":"Foundation for Innovative New Diagnostics","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-4839","authenticated-orcid":true,"given":"Derek T.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April L.","family":"Borkman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina","place":["Charleston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold","family":"Ellner","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Dorman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina","place":["Charleston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01e92na05","id-type":"ROR","asserted-by":"publisher"}],"name":"Frontier Science Foundation","place":["Brookline, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-1571","authenticated-orcid":true,"given":"David","family":"Alland","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5499-0204","authenticated-orcid":false,"given":"Soumitesh","family":"Chakravorty","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/014ye1258","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine, Rutgers New Jersey Medical School","place":["Newark, USA"]},{"name":"Cepheid Inc.","place":["Sunnyvale, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.54394\/CJQU6666"},{"key":"e_1_3_5_3_2","volume-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment - drug-susceptible tuberculosis treatment","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. 2022. WHO consolidated guidelines on tuberculosis: module 4: treatment - drug-susceptible tuberculosis treatment. Geneva."},{"key":"e_1_3_5_4_2","volume-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. 2022. WHO consolidated guidelines on tuberculosis: module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Geneva."},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00610-21"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2014.02.005"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32810-2"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00526-2021"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piab097"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3881-y"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00812-17"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00001-6"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.8.2987-2990.2001"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760150100"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152933"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq519"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3638-z"},{"key":"e_1_3_5_18_2","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance: second edition","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. 2023. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance: second edition. 1st ed. World Health Organization, Geneva.","edition":"1"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413930"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30422-5"},{"key":"e_1_3_5_21_2","unstructured":"World Health Organization. 2019. Global tuberculosis report 2019. Vol. 66. Geneva Switzerland World Health Organization"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00498-X"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad684"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02263-20"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3767"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2016.10.007"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30407-8"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir406"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000150"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3079-4"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa873"},{"key":"e_1_3_5_32_2","volume-title":"Use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin: policy update","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin: policy update. World Health Organization."},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.03.012"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.12701\/jyms.2024.00024"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107605"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60438-8"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz106"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05638-11"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003008"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01354-2017"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119628"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02314-20"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.4.1455-1464.2005"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MGM2-0014-2013"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00452-7"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01662-16"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01463-09"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm765"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.09.014"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06394-z"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology12040525"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_607_22"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt284"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01599-17"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00925-22"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1265390"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.16.0843"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.366"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2016.09.006"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00289-17"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2020.06.013"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz932"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.04.006"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102199"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2024.05.004"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S358301"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.01100-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.01100-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:01:42Z","timestamp":1779973302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.01100-25"}},"subtitle":[],"editor":[{"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,13]]}},"alternative-id":["10.1128\/jcm.01100-25"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01100-25","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"2025-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01100-25"}}